Diffuse Large B-cell Lymphoma: Oncology Hour

The event is hosted by Fiona Evans, Lead Patient Relations Coordinator at Massive Bio.

Watch Diffuse Large B-cell Lymphoma (DLBCL): Oncology Hour with expert oncologist Jose Sandoval, MD, an assistant member the Malignant Hematology and Cellular Therapy at Moffit Cancer Center. Submit the form on this page to watch the full event video or attend future free events on the Massive Bio Facebook page.

Diffuse Large B-cell Lymphoma (DLBCL): Oncology Hour discussed topics including:

• DLBCL and how common is it compared to other lymphomas
• Symptoms and diagnosis of DLBCL
• The standard of care for patients with DLBCL
• Treatment options such as CAR T cell therapy, stem cell transplantation, targeted therapy, and radiation therapy
• Clinical trials for DLBCL

DLBCL, a form of non-Hodgkin’s lymphoma is a common blood cancer that is fast-growing, or aggressive. It starts in the lymph nodes and can spread throughout the rest of the body. Treatment for DLBCL patients depends on various factors.

Clinical trials test scientific advancements in cancer treatment for cancers of all types with biomarkers identified in genomic testing. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. Cancer patients might gain access to promising drugs and innovative treatments long before they’re made available to the public.

Diffuse Large B-cell Lymphoma (DLBCL): Oncology Hour aired on Tuesday, April 12^th at 4:30 pm ET. Fill out the form to watch the event now. Tune in to learn about lymphoma clinical trials, DLBCL treatment options, how Massive Bio can help cancer patients, and more!